Freeze of Gait Companies

Acorda Therapeutics: In July 2023, Acorda Therapeutics received FDA approval for INBRIJA (levodopa/carbidopa/inhibitor) oral film, a fast-acting levodopa treatment for "off" episodes in Parkinson's disease, including FoG.

Medtronic: In March 2023, Medtronic announced the launch of its DBS Therapy for Parkinson's disease, a deep brain stimulation system that can help manage symptoms like FoG.

Gondola Medical Technologies: In December 2023, Gondola Medical Technologies secured EUR 27 million in funding to expand its development and commercialization of its GaitGuard system, a wearable device that uses electrical stimulation to improve gait in patients with Parkinson's disease and FoG.

Ustep: In January 2024, Ustep received FDA clearance for its Walk with Path system, a wearable device that uses biofeedback and augmented reality to help patients with Parkinson's disease improve gait and reduce FoG episodes.

• Teva Pharmaceuticals (Israel)


• Sun Pharmaceutical Industries Ltd (India)


• Viatris Inc (US)


• Gondola Medical Technologies SA (Switzerland)


• Gyenno Technologies Co., Ltd. (China)


• Beats Medical Limited (Ireland)


• Agilitas (Australia)


• Walk with Path (Vesterbro)


• MedEXO Robotics (Hong Kong)


• Ustep (US)